Lantheus Holdings, Inc. Amortization of Debt Issuance Costs and Discounts
Lantheus Holdings, Inc. (LNTH) reported Amortization of Debt Issuance Costs and Discounts of $3.23 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-11-02
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2023-09-30 was $1.07M, a 335.77% increase year-over-year.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2023-06-30 was $1.07M, a 337.96% increase year-over-year.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2023-03-31 was $1.08M, a 339.84% increase year-over-year.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-09-30 was $246.00K, a 0.41% increase year-over-year.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2018 was $0.00.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2016 was $1.90M.
- Lantheus Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2015 was $0.00.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2023-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.15M derived: sum of 2 quarters · filed 2023-11-02 | $3.23M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.15M 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | $1.08M 10-Q · filed 2023-05-04 | |||
| 2022-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $491.00K derived: sum of 2 quarters · filed 2023-11-02 | $737.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $491.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $246.00K 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $491.00K derived: sum of 2 quarters · filed 2022-11-03 | $430.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $185.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$61.00K 10-Q · filed 2022-04-29 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-20 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $0.00 10-K · filed 2019-02-20 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | ||
| 2016-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.90M derived: sum of 2 quarters · filed 2019-02-20 | $1.90M 10-K · filed 2019-02-20 | |
| 2016-09-30 | $1.42M 10-Q · filed 2017-11-02 | $1.42M 10-Q · filed 2017-11-02 | ||
| 2015-12-31 | $0.00 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |